Compounds > gusperimus
Page last updated: 2024-08-23

gusperimus and Thrombocytopenia

gusperimus has been researched along with Thrombocytopenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akamatsu, Y; Enomoto, Y; Kawagishi, N; Satoh, K; Satomi, S; Sekiguchi, S1
Abe, F; Ito, J; Nemoto, K; Ogino, M; Sugawara, Y; Takeuchi, T1
Koike, T; Mae, T; Matsuura, E; Nemoto, K; Saiga, K1

Other Studies

3 other study(ies) available for gusperimus and Thrombocytopenia

ArticleYear
Usage of deoxyspergualin on steroid-resistant acute rejection in living donor liver transplantation.
    The Tohoku journal of experimental medicine, 2006, Volume: 208, Issue:3

    Topics: ABO Blood-Group System; Acute Disease; Blood Component Removal; Blood Group Incompatibility; Child; Child, Preschool; Female; Follow-Up Studies; Graft Rejection; Granulocyte Colony-Stimulating Factor; Guanidines; Humans; Immunosuppressive Agents; Infant; Leukopenia; Liver Transplantation; Living Donors; Male; Platelet Transfusion; Retrospective Studies; Thrombocytopenia; Time Factors; Treatment Outcome

2006
Improvement of mitomycin C- and cyclophosphamide-induced thrombocytopenia and leucocytopenia by prior treatment with deoxyspergualin in dogs.
    British journal of haematology, 1994, Volume: 87, Issue:3

    Topics: Animals; Cyclophosphamide; Dogs; Guanidines; Immunosuppressive Agents; Leukocyte Count; Leukopenia; Male; Mitomycin; Thrombocytopenia

1994
Autoimmune-prone (NZW x BXSB)F1 (W/BF1) mice escape severe thrombocytopenia after treatment with deoxyspergualin, an immunosuppressant.
    British journal of haematology, 1995, Volume: 91, Issue:3

    Topics: Animals; Antibodies; Blood Platelets; Guanidines; Immunosuppressive Agents; Male; Mice; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia

1995